Browse the evidence

Saturated fatty acids (SFA) promote greater long-term weight gain compared to unsaturated fatty acids (MUFA/PUFA) primarily due to lower diet-induced thermogenesis (DIT) and reduced energy expenditure, despite potentially stimulating appetite-regulating hormones like CCK and PYY more strongly.

Focus on the quality of fat rather than just eliminating it. Replacing saturated fats (found in butter, fatty meats) with unsaturated fats (olive oil, nuts, fish) may support weight control by boosting your body's energy expenditure, even if total calories remain similar.

Monounsaturated fatty acids (MUFA) and Polyunsaturated fatty acids (PUFA) stimulate higher diet-induced thermogenesis (DIT) and energy expenditure compared to Saturated fatty acids (SFA), which may aid in long-term weight maintenance despite having weaker effects on acute appetite suppression.

Incorporate more unsaturated fats (like olive oil, avocados, nuts) into your diet. Even if they don't make you feel as full as other foods, they may help your body burn more calories at rest and after meals compared to saturated fats.

Weight cycling (yo-yo dieting) is associated with increased cardiovascular risk and morbidity, whereas sustained weight loss or maintenance reduces risk.

Avoid yo-yo dieting. Repeatedly losing and regaining weight increases your risk of heart disease. Focus on sustainable weight loss or maintenance. If you struggle with weight cycling, seek professional help to establish stable habits.

Greater degrees of weight reduction achieved with tirzepatide are associated with greater improvements in health-related quality of life (HRQoL), particularly when weight loss is ≥5%.

With tirzepatide, you don't need to lose a massive amount of weight to see benefits. Losing 5% or more of your body weight is associated with noticeable improvements in how you feel and function, with greater losses leading to even better outcomes.

Lifestyle modification resulting in 7% weight loss and 150-175 minutes per week of physical activity can reduce the relative risk of obesity-related cancer by 16%, suggesting the effects of obesity on cancer risk may be reversible.

Aim for a 7% weight loss and 175 minutes of physical activity per week. While the cancer risk reduction in the major trial was not statistically significant, the trend suggests that maintaining a healthy weight through diet and exercise is a powerful way to lower your cancer risk.

Sustained lockdown-induced sedentary behavior and dietary shifts in healthy adults cause significant worsening of cardiovascular risk factors, including increased BMI, body fat, LDL cholesterol, blood glucose, and blood pressure.

Maintain physical activity and monitor dietary intake during periods of restricted movement. The study shows that even healthy adults experience measurable declines in metabolic health (weight, lipids, glucose) when sedentary, highlighting the need for proactive lifestyle management during lockdowns or similar restrictions.

Very low-calorie diets (VLCD) are suitable for short-term use in specific clinical populations, such as those with Type 2 Diabetes (T2D), to improve glycemic control and cardiovascular risk factors, but are not recommended for long-term use or for older adults at risk of sarcopenia.

If you have Type 2 Diabetes, a very low-calorie diet might help your blood sugar and weight quickly, but only under doctor supervision and for a short time. Do not use this if you are older and worried about muscle loss.

Bioelectrical Impedance Spectroscopy (BIS) is recommended as a feasible, noninvasive, and inexpensive method to assess body fat mass and visceral fat, explaining 80-90% of variance in fat mass compared to gold standards.

Bioelectrical Impedance Spectroscopy (BIS) is recommended for obesity trials as a feasible alternative to expensive imaging. It provides a good estimate of body fat and visceral fat, explaining up to 90% of the variance compared to gold-standard methods like DXA.

Calculated Resting Energy Expenditure (REE) using the Mifflin-St. Jeor equation is recommended over direct calorimetry for large clinical trials due to feasibility, though direct measurement is suggested if resources allow.

For large obesity trials, calculating Resting Energy Expenditure (REE) using the Mifflin-St. Jeor equation is the recommended standard. It is feasible, cost-effective, and correlates well with direct calorimetric measurements.

Physical activity improves metabolic health and reduces blood glucose levels independently of weight loss and insulin signaling pathways.

You do not need to lose weight to get the metabolic benefits of exercise. Even if your weight stays the same, physical activity helps your muscles take up glucose without relying on insulin, which is crucial for preventing or managing type 2 diabetes and metabolic syndrome. Focus on consistency rather than just the number on the scale.

Humans exhibit sensitivity to meal energy density (ED) by adjusting meal size to minimize acute aversive effects of overconsumption, specifically through a nonlinear relationship where calorie-content signals dominate at high EDs (>1.41-1.75 kcal/g).

Your body naturally regulates intake based on how energy-dense your food is. When you eat foods with high energy density (above ~1.5 kcal/g), your body uses calorie-sensing signals to reduce your meal size, preventing overconsumption. This is a learned and biological response, not just stomach volume. Focus on understanding that high-energy foods trigger different satiety signals than low-energy, high-volume foods.

Anti-obesity medications and bariatric surgery improve Obstructive Sleep Apnea (OSA) severity, measured by Apnea-Hypopnea Index (AHI), in direct proportion to the percentage of body weight lost, regardless of the specific intervention type.

If you have OSA and are overweight, losing weight through medication or surgery will improve your sleep apnea severity. For every 1% of body weight you lose, your Apnea-Hypopnea Index (AHI) drops by about 0.45 events per hour. This benefit is consistent whether you lose the weight through medication or surgery, meaning you can choose the method that fits your lifestyle and risk tolerance while expecting similar proportional improvements in your sleep apnea.

Metabolic adaptation (reduced energy expenditure beyond that predicted by body composition changes) occurs during active weight loss but typically normalizes after body weight stabilizes, although it may persist long-term in specific contexts such as extreme caloric restriction.

When you lose weight, your body burns fewer calories, but this is largely because you weigh less and have less metabolically active tissue. While your metabolism may stay lower than it was at your starting weight for a while, it often normalizes once your weight stabilizes. Don't assume long-term failure is inevitable; focus on maintaining your new weight, as the metabolic penalty is often overstated and may resolve over time.

Low-carbohydrate diets lead to significant short-term reductions in body weight, BMI, and waist circumference in overweight/obese T2DM patients, but these advantages may attenuate over the long term (6-24 months) compared to balanced low-calorie diets.

You can expect to lose weight, BMI, and waist circumference quickly in the first few months on a low-carb diet. However, do not be discouraged if your weight loss slows down after 6 months; studies show that over the long term, your results will likely be similar to those of any balanced, calorie-controlled diet. The key is sustainability and adherence rather than expecting indefinite rapid loss.

Intensive lifestyle intervention in patients with Type 2 Diabetes and obesity does not significantly reduce major cardiovascular events compared to standard care, although weight loss of 10% or more is associated with a lower risk.

For Type 2 Diabetes patients, intensive lifestyle changes alone may not significantly reduce heart events compared to standard care, unless you achieve at least 10% weight loss. Focus on sustainable weight loss and combine lifestyle changes with medical therapies for best heart protection.

Intermittent fasting variants (ADF, TWF, TRE) produce weight and fat loss effects equivalent to daily caloric restriction (DCR) when total energy intake is matched, with no inherent metabolic advantage to fasting timing.

Use intermittent fasting if it helps you eat less, not because you think it burns fat faster. If you can maintain a caloric deficit with standard meal timing, you will lose fat at the same rate. Prioritize protein intake and resistance training to protect muscle, as fasting does not inherently spare muscle.

Higher rates of in vivo adipose triglyceride (TG) synthesis and de novo lipogenesis (DNL) are negatively correlated with body weight loss in women with obesity.

You might think that if your body is good at making new fat (de novo lipogenesis), it would be harder to lose weight. However, this study found the opposite: women who lost more weight actually had higher rates of fat synthesis and turnover in their fat tissue. This suggests that a dynamic, active fat metabolism might be helpful for weight loss, rather than a slow, stagnant one. It highlights that fat turnover is complex and not just about 'making fat'.

Despite significant losses in absolute muscle strength and lean mass, relative muscle strength (strength per unit of body weight or lean mass) and physical function (sit-to-stand time, 6-minute walk distance) improve significantly within one year of metabolic/bariatric surgery, regardless of the specific surgical procedure.

You will lose some muscle mass and absolute strength after surgery, which is normal. However, because you are losing a lot of body weight, your relative strength (strength for your body size) and physical function (walking, standing up) will likely improve. Focus on maintaining muscle through protein intake and light activity rather than fearing the inevitable loss.

Very low calorie diets (VLCD) produce superior short-term weight loss (approx. 4 kg more than behavioral programs) and modest long-term benefits (1.3-1.4 kg) compared to standard behavioral weight loss programs, though long-term maintenance requires adjunctive support.

If you need significant weight loss, a Very Low Calorie Diet (VLCD) under medical supervision produces more weight loss than standard diet advice alone, both immediately and up to 5 years later. However, because regain is common, you should plan for long-term support (like meal replacements or medication) to keep the weight off.

Bariatric surgery's glycemic benefits in patients with BMI <35 kg/m2 are primarily driven by caloric restriction and weight loss rather than unique metabolic or hormonal mechanisms.

For patients with BMI <35, surgery is not a 'metabolic cure' distinct from weight loss. The glycemic benefits are largely due to the caloric restriction and weight loss achieved. While surgery is more effective at producing and sustaining this weight loss than lifestyle changes alone, the underlying mechanism is energy balance, not a unique surgical hormone effect. Patients should understand that achieving similar weight loss through other means could yield similar metabolic improvements, though sustaining that loss is the primary challenge.

Consuming a gluten-free meal results in a significantly lower postprandial thermogenic response (calorie burn) compared to iso-caloric whole food or ultra-processed meals in young women.

If you are eating gluten-free products for weight loss, be aware that they may not offer a metabolic advantage. This study found that gluten-free meals resulted in lower calorie burning (thermogenesis) after eating compared to both whole food and ultra-processed meals, provided the calories and macronutrients were the same. Focus on whole, unprocessed foods rather than just the absence of gluten for optimal metabolic response.

Lifestyle interventions for type 2 diabetes prevention in women with a history of gestational diabetes are only effective in reducing T2DM risk if participants have a baseline mean BMI of 30 kg/m2 or higher.

If you have a history of gestational diabetes and a BMI of 30 or higher, lifestyle interventions (diet and exercise) are highly effective at preventing type 2 diabetes. If your BMI is lower, these interventions may not significantly reduce your T2DM risk, though they may still help with weight management.

Fixed-amount food vouchers are less effective per person in larger households, requiring higher dollar values to achieve the same dietary improvement as in smaller households.

If you manage a food assistance program, do not give a flat $20 voucher to a family of 8 and expect the same per-person dietary benefit as for a single person. The subsidy is diluted. To help larger families achieve similar health outcomes, you must either increase the total dollar amount or provide additional non-financial support to help them navigate purchasing for more people.

Metabolic bariatric surgery (specifically malabsorptive procedures like Roux-en-Y gastric bypass) offers higher remission rates for Type 2 Diabetes than restrictive procedures (like sleeve gastrectomy), particularly in patients with severe obesity (BMI ≥ 35).

If you have severe obesity (BMI 35+) and Type 2 Diabetes, metabolic surgery (specifically bypass) is the most effective intervention for remission, offering double the success rate of sleeve gastrectomy. While invasive, it provides superior long-term glycemic control and lower relapse rates compared to other surgical options.